Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
In one of biotech’s hottest areas and with big partners like…
Clinical
CytoDyn Announces Execution of Exclusive Agreement with American Regent for Distribution…
Commercial
Rexgenero Appoints Dr Gilbert Wagener as Senior Vice President and Chief…
Commercial
Abivax treats first patient in Phase 2b/3 ABX464 Covid-19 clinical trial
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
UK mulls joining EU coronavirus vaccines strategy – FirstWord Pharma
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
In one of biotech’s hottest areas and with big partners like…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Clinical
Gilead’s Veklury gains conditional EU approval for treatment of COVID-19 –…
Clinical
The European Commission has Granted Orphan Medicinal Product Designation in the…
Clinical
Hydroxychloroquine found to significantly cut death rates in new COVID-19 study…
Clinical
Discovery of new step in how brain cells work could lead…
Home
Therapy areas
Others
Others
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Others
Johnson & Johnson ramps up Tylenol production as demand surges – FirstWord Pharma
Firstwordpharma News
-
March 14, 2020
Others
National Association of Cannabis Businesses Adopts Standards for Safe Production and Storage of Cannabis-Infused Products
Others
Bill Supporting U.S. Pharma Manufacturing Introduced to Senate
Others
BioSpace Movers & Shakers, March 13
Others
Friday Five – The pharma week in review (13 March 2020) – FirstWord Pharma
Others
ICER Releases Evidence Report on Treatments for Sickle Cell Disease –...
Firstwordpharma News
-
March 13, 2020
0
Others
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Firstwordpharma News
-
March 13, 2020
0
Others
Rubius Therapeutics Reprioritizes Pipeline for Cancer, Autoimmune Disorders
Biospace News
-
March 13, 2020
0
Others
Novel Gene Therapy Generated New Functional Neurons in Mouse Models of...
Firstwordpharma News
-
March 12, 2020
0
Others
BioSpace Global Roundup, March 12
Biospace News
-
March 12, 2020
0
1
2
3
...
240
Page 1 of 240
- Advertisement -
MOST POPULAR
Regeneron Announces Upcoming Investor Conference Presentations on November 2019
October 18, 2019
UK, German cost-effectiveness bodies unconvinced by Bayer’s TRK inhibitor Vitrakvi
January 17, 2020
Akili and Shionogi Announce Strategic Partnership to Develop and Commercialize Digital...
March 7, 2019
Laurent Pharmaceuticals Receives a CAD 2.7M Financing from BioMed Propulsion Fund
December 4, 2019
Load more
HOT NEWS
Commercial
Findings Reveal Lack of Participants in Critical Research is Caused by...
Phase II
UCB Presents Final Results from Phase II Study of Rozanolixizumab in...
Dermatology
Lilly Presents Positive Results for Taltz (ixekizumab) in Pediatric Patients with...
Others
Henlius Trastuzumab HLX02 Filed New Drug Application
